![]() |
|
|
Vol. 55, Issue 3, 489-496, March 1999
-Aminobutyric Acid Type A
Receptors by the Neuroactive Steroid Dehydroepiandrosterone Sulfate in
Posterior and Intermediate Pituitary
Department of Physiology, University of Wisconsin Medical School,
Madison, Wisconsin (M.B.J.), and
Royal Danish School of Pharmacy,
Copenhagen, Denmark (S.L.H., B.F.)
Dehydroepiandrosterone sulfate (DHEAS) is a neuroactive steroid
with antagonist action at
-aminobutyric acid type A
(GABAA) receptors. Patch-clamp techniques were used to
investigate DHEAS actions at GABAA receptors of the rat
pituitary gland at two distinct loci: posterior pituitary nerve
terminals and intermediate pituitary endocrine cells. The GABA
responses in these two regions were quite different, with posterior
pituitary responses having smaller amplitudes and desensitizing more
rapidly and more completely. DHEAS blockade of GABAA
receptors in the two regions also was different. In posterior
pituitary, a site with an apparent dissociation constant of 15 µM
accounted for most of the blockade, but a small fraction of blockade
may be related to a site with a dissociation constant in the nanomolar
range. In the intermediate lobe, DHEAS sensitivities in the nanomolar
and micromolar ranges were clearly evident, in proportions that varied
widely from cell to cell. Regardless of whether the GABA response of a
cell was highly sensitive or weakly sensitive to DHEAS, GABA alone
evoked currents that were indistinguishable in terms of amplitude,
desensitization kinetics, and GABA sensitivity. Thus, the structural
elements responsible for DHEAS blockade have a highly selective impact on receptor function. GABAA receptors with nanomolar
sensitivity to DHEAS have not been described previously. This suggests
that DHEAS may have an important role in the modulation of neuropeptide secretion, and the diverse properties of GABAA receptors in
the rat pituitary provide mechanisms for selective regulation of the different peptidergic systems of this gland.
This article has been cited by other articles:
![]() |
R. M. LOSEL, E. FALKENSTEIN, M. FEURING, A. SCHULTZ, H.-C. TILLMANN, K. ROSSOL-HASEROTH, and M. WEHLING Nongenomic Steroid Action: Controversies, Questions, and Answers Physiol Rev, July 1, 2003; 83(3): 965 - 1016. [Abstract] [Full Text] [PDF] |
||||